TuHURA Biosciences, Inc.
HURA· Nasdaq
Filed May 15, 2015 · 10-Q · 45 days after period end · 0001013762-15-000525
| Metric | Q3 2015 | Q3 2012 |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | $437.58K | -$427.83K |
| EPS Diluted | $0.04 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end